Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schellekens

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|April 19, 1979
Is it true what they say about interferon?W Weimar, H Schellekens
The Journal of General Virology|January 1, 1980
Influence of input multiplicity of infection on the antiviral activity of interferonL Stitz, H Schellekens
Lancet (London, England)|March 15, 1980
Interferon therapy for chronic hepatitis BW Weimar, H Schellekens
Developments in Biologicals|May 24, 2003
Immunogenicity of biopharmaceuticals. The European perspectiveH Schellekens, N Casadevall
The Netherlands Journal of Medicine|January 1, 1978
A future for exogenous interferon therapy?W Weimar, H Schellekens
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|July 1, 1979
Prophylaxis and therapy of HBsAg positive hepatitisW Weimar, H Schellekens
Scandinavian Journal of Immunology|January 1, 1981
Induction of natural killer cell activity and allocytotoxicity in human peripheral blood lymphocytes after mixed lymphocyte cultureR L Bolhuis, H Schellekens
Developments in Biologicals|May 24, 2003
The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug developmentP A Patten, H Schellekens
Journal of Virological Methods|January 1, 1980
Simple method for measuring growth inhibition by interferon of cells in monolayerH Schellekens, L W Stitz
Transplantation Proceedings|April 1, 1988
Vascular endothelium in allograft rejectionD Leszczynski, H Schellekens, P Häyry
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|April 19, 1979
Is it true what they say about interferon?W Weimar, H Schellekens
The Journal of General Virology|January 1, 1980
Influence of input multiplicity of infection on the antiviral activity of interferonL Stitz, H Schellekens
Lancet (London, England)|March 15, 1980
Interferon therapy for chronic hepatitis BW Weimar, H Schellekens
Developments in Biologicals|May 24, 2003
Immunogenicity of biopharmaceuticals. The European perspectiveH Schellekens, N Casadevall
The Netherlands Journal of Medicine|January 1, 1978
A future for exogenous interferon therapy?W Weimar, H Schellekens
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|July 1, 1979
Prophylaxis and therapy of HBsAg positive hepatitisW Weimar, H Schellekens
Scandinavian Journal of Immunology|January 1, 1981
Induction of natural killer cell activity and allocytotoxicity in human peripheral blood lymphocytes after mixed lymphocyte cultureR L Bolhuis, H Schellekens
Developments in Biologicals|May 24, 2003
The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug developmentP A Patten, H Schellekens
Journal of Virological Methods|January 1, 1980
Simple method for measuring growth inhibition by interferon of cells in monolayerH Schellekens, L W Stitz
Transplantation Proceedings|April 1, 1988
Vascular endothelium in allograft rejectionD Leszczynski, H Schellekens, P Häyry
Pageof 16